Skip to Content
Search Menu

Solunulkoisen DNA:n eheysmittaus voi auttaa aggressiivisen rintasyövän tunnistamisessa

Solunulkoista DNA:ta (cell-free DNA, cfDNA) hyödyntävä nestebiopsia on lupaava vaihtoehto perinteisille kasvainnäytteistä tehtäville tutkimuksille.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Asiaan liittyvä sisältö

P-VERIFY: Kattava tosielämän kokonaiselossaolon (OS) vertaileva analyysi CDK4/6-estäjistä yhdessä aromataasi-inhibiittorin kanssa HR+/HER2- metastasoituneessa rintasyövässä

/ Pfizer
Breast cancer
Per Hall

Making Primary Breast Cancer Prevention a Reality

/ Per Hall
Breast cancer Play the Video 03:48
Philip Poortmans

Breast Cancer Treatment: The Role of Boost Radiation Therapy in Reducing Recurrence Risks

/ Philip Poortmans
Breast cancerOnkologisk Forum 2024 Play the Video 06:45
Demet Özcan

Breast Cancer: The Prognostic Value of Tumor-Infiltrating Lymphocytes

/ Demet Özcan
Breast cancerSABCS24 Play the Video 06:43
Hope Rugo

Abemaciclib Shows Significant Benefit for HR-Positive HER2-Negative Patients with Advanced Breast Cancer

/ Hope S. Rugo
Breast cancer Play the Video 11:57
Maren Marie Andreassen

MRI-Based AI Can Detect Responsive Treatment of Breast Cancer After Three Weeks of Therapy

/ Maren Marie Andreassen
Breast cancerNBCN Play the Video 02:20
Adam Brufsky

SABCS 2024: Palbociclib, Abemaciclib, and Ribociclib Can Be Considered Equivalent in the Treatment of HR-Positive/HER2-Negative Metastatic Breast Cancer

/ Adam Brufsky
Breast cancerSABCS24 Play the Video 08:56
Stefania Katrin Finnsdottir

The Need to Improve Compliance with Adjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer

/ Stefanía Katrín Finnsdóttir
Breast cancerNBCN Play the Video 02:45
Minna Tanner

The Approval of New Drugs Should Be Harmonized Across the Nordic Countries

/ Minna Tanner
Breast cancerNBCN Play the Video 03:20
Back to top